Bioactivity:

Epalrestat, an aldose reductase inhibitor, is well tolerated in Long-term therapy. It can effectually ameliorate the associated symptoms of diabetic neuropathy and delay the progression of the disease, particularly in patients with limited microangiopathy

CAS nr:

82159-09-9

Purity:

98%

Molecular Weight:

319,39

SMILES:

C(=O)(CN1C(=S)S/C(=C\C(=C\c2ccccc2)\C)/C1=O)O

Formula:

C15H13NO3S2

Pathway:

Metabolism,Endocrinology/Hormones

Target:

Reductase,Reductase